Pharma Law USA
Boston, MA 02116
Event summary
Cooley is a proud sponsor of the 2024 Pharma Law USA conference. Presented by Informa, this two-day event examined antitrust, intellectual property, fraud, compliance and regulation to dissect the latest legal developments in the pharmaceutical industry.
Featured agenda item
Wednesday, October 9, 2024 | 10:00 – 10:50 am EDT
Merger Control: Review of FTC Guidelines & Lessons Learnt From Recent Mergers
Cooley partner Megan Browdie spoke on this panel, covering topics such as:
- Review of Federal Trade Commission’s (FTC) new merger guidelines and the implications for pharma mergers
- Update on the FTC and Department of Justice Multilateral Pharmaceutical Merger Task Force
- Public inquiry into private equity’s role in healthcare
- Acquisitions of nascent competitors
- Lessons learned from recent mergers
For more information, please email Yena Lee.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.